Blue Matter Blog
February 18, 2019
On February 1, Blue Matter launched its first Global Happiness Survey. This monthly survey asks Blue Matter team members around the world to rate their current levels of happiness. Even though the global survey just got started, the idea of measuring team happiness has a lengthy history within the firm, starting as regional efforts in …
February 11, 2019
At Blue Matter, we love what we do. The work is interesting, and we always feel like we’re learning something new. There’s also a sense that, in our own small way, we’re joining in the fight against some of the world’s worst diseases. Our team members have a passion for the areas in which they …
May 25, 2018
Blue Matter Academy (BMA) is Blue Matter Consulting’s in-house learning and development organization. Officially launched in 2017, BMA’s goal is to provide ongoing learning opportunities for all Blue Matter team members. Recently, Karen Foster, Learning Strategist and Head of Blue Matter Academy, took the time to answer some common questions about the Academy and Blue …
We use cookies to provide website functionality and give you the best possible experience. Our Cookie Statement provides more information and explains how to amend your cookie settings.
By pressing the “Accept Cookies” button, the user accepts all Cookies on the Website. View our Cookie Statement.
As a founder and managing partner, Ashwin brings 17+ years of life science consulting experience to Blue Matter. Prior to starting Blue Matter, he was Senior VP, Head of Brand Management / Business Development at Campbell Alliance. He is a physician and MBA by training and his specialties include product and portfolio strategy.
As a founder and managing partner of Blue Matter, Emily brings over 20 years of life science experience. Prior to Blue Matter, Emily was Senior VP and head of the San Francisco office for Campbell Alliance. Her specialties include product and portfolio strategy and oncology product launches.
As head of Blue Matter Europe, George brings extensive experience from 16+ years in life science consulting. Previously, George was GM / Head of Europe for Campbell Alliance. His specialties are commercial excellence, organizational design and customer engagement strategy.
Jeron brings 15+ years of life science experience, including more than 10 years in consulting. Previously, Jeron was Corporate Development and Commercial Excellence Lead at Campbell Alliance. His specialties include product, portfolio, and corporate strategy in oncology and diagnostics.
Thomas has 11+ years of experience in life science consulting (bio-pharma / diagnostic). He was formerly VP of Brand Management and Medical Affairs at Campbell Alliance. His specialties include product commercialization and Medical Affairs organization development in oncology and rare diseases.
Pankaj brings an impressive 25+ years of life science experience in industry and consulting to Blue Matter, having held increasingly senior positions at GSK, Bristol-Myers Squibb and Norgine. He was formerly Head of Consulting at IDEA, and he specializes in product, franchise and portfolio strategy, new product planning, and oncology launch readiness. He holds a BSc Pharm from UCL and an MBA from Imperial College London.
With over 10 years in research and consulting for the life sciences, Mary’s primary focus is on product strategy, franchise/portfolio strategy, launch planning, and commercial excellence in oncology and other TAs. She has a PhD in Biology from MIT and also hails from Campbell Alliance.
Jonny has over 12 years of life sciences experience across industry and consulting. His primary focus is on launch planning, product strategy, and lifecycle management in oncology and other specialty TAs. Formerly a senior manager at Campbell Alliance, he holds a PhD in Biochemical Engineering from UCL.
Dirk brings extensive industry experience to Blue Matter. His background spans 25+ years, with senior commercial roles in leading biopharmaceutical companies such as Shire, Roche / Genentech, and Amgen. His specialties include commercial strategy development, lifecycle management, and marketing, with a focus on rare diseases. He has a degree in biochemistry, as well as a PhD in Molecular Immunology from the University of Basel.